Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1.

Literature DB >> 28344316

Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1.

A Cosson^1,2,3, E Chapiro^1,2,4, N Bougacha^1,2,3, J Lambert⁵, L Herbi^1,2,3, H-A Cung⁴, C Algrin⁴, B Keren⁶, F Damm⁷, C Gabillaud⁴, M-N Brunelle-Navas^1,2,3, F Davi^1,2,4, H Merle-Béral^1,2,4, M Le Garff-Tavernier^1,2,4, D Roos-Weil⁷, S Choquet⁴, M Uzunov⁴, V Morel⁴, V Leblond⁴, K Maloum⁴, S Lepretre⁸, P Feugier⁹, C Lesty⁴, J Lejeune⁵, L Sutton¹⁰, Y Landesman¹¹, S A Susin^1,2,3, F Nguyen-Khac^1,2,4.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2017 PMID： 28344316 DOI： 10.1038/leu.2017.100

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

× No keyword cloud information.

18 in total

1. Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages.

Authors: Elise Chapiro; Nathalie Leporrier; Isabelle Radford-Weiss; Christian Bastard; Hossein Mossafa; Dominique Leroux; Isabelle Tigaud; Marc De Braekeleer; Christine Terré; Françoise Brizard; Evelyne Callet-Bauchu; Stéphanie Struski; Lauren Veronese; Sandra Fert-Ferrer; Sylvie Taviaux; Claude Lesty; Frédéric Davi; Hélène Merle-Béral; Olivier A Bernard; Laurent Sutton; Sophie D Raynaud; Florence Nguyen-Khac
Journal: Leuk Res Date: 2009-04-29 Impact factor: 3.156

2. SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients.

Authors: S Jeromin; S Weissmann; C Haferlach; F Dicker; K Bayer; V Grossmann; T Alpermann; A Roller; A Kohlmann; T Haferlach; W Kern; S Schnittger
Journal: Leukemia Date: 2013-09-12 Impact factor: 11.528

3. Acquired initiating mutations in early hematopoietic cells of CLL patients.

Authors: Frederik Damm; Elena Mylonas; Adrien Cosson; Kenichi Yoshida; Véronique Della Valle; Enguerran Mouly; M'boyba Diop; Laurianne Scourzic; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Yoshikane Kikushige; Frederick Davi; Jérôme Lambert; Daniel Gautheret; Hélène Merle-Béral; Laurent Sutton; Philippe Dessen; Eric Solary; Koichi Akashi; William Vainchenker; Thomas Mercher; Nathalie Droin; Seishi Ogawa; Florence Nguyen-Khac; Olivier A Bernard
Journal: Cancer Discov Date: 2014-06-11 Impact factor: 39.397

4. Selinexor suppresses downstream effectors of B-cell activation, proliferation and migration in chronic lymphocytic leukemia cells.

Authors: Y Zhong; D El-Gamal; J A Dubovsky; K A Beckwith; B K Harrington; K E Williams; V M Goettl; S Jha; X Mo; J A Jones; J M Flynn; K J Maddocks; L A Andritsos; D McCauley; S Shacham; M Kauffman; J C Byrd; R Lapalombella
Journal: Leukemia Date: 2014-01-13 Impact factor: 11.528

Review 5. Nuclear export of proteins and drug resistance in cancer.

Authors: Joel G Turner; Jana Dawson; Daniel M Sullivan
Journal: Biochem Pharmacol Date: 2011-12-20 Impact factor: 5.858

6. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.

Authors: Xose S Puente; Magda Pinyol; Víctor Quesada; Laura Conde; Gonzalo R Ordóñez; Neus Villamor; Georgia Escaramis; Pedro Jares; Sílvia Beà; Marcos González-Díaz; Laia Bassaganyas; Tycho Baumann; Manel Juan; Mónica López-Guerra; Dolors Colomer; José M C Tubío; Cristina López; Alba Navarro; Cristian Tornador; Marta Aymerich; María Rozman; Jesús M Hernández; Diana A Puente; José M P Freije; Gloria Velasco; Ana Gutiérrez-Fernández; Dolors Costa; Anna Carrió; Sara Guijarro; Anna Enjuanes; Lluís Hernández; Jordi Yagüe; Pilar Nicolás; Carlos M Romeo-Casabona; Heinz Himmelbauer; Ester Castillo; Juliane C Dohm; Silvia de Sanjosé; Miguel A Piris; Enrique de Alava; Jesús San Miguel; Romina Royo; Josep L Gelpí; David Torrents; Modesto Orozco; David G Pisano; Alfonso Valencia; Roderic Guigó; Mónica Bayés; Simon Heath; Marta Gut; Peter Klatt; John Marshall; Keiran Raine; Lucy A Stebbings; P Andrew Futreal; Michael R Stratton; Peter J Campbell; Ivo Gut; Armando López-Guillermo; Xavier Estivill; Emili Montserrat; Carlos López-Otín; Elías Campo
Journal: Nature Date: 2011-06-05 Impact factor: 49.962

7. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.

Authors: Lili Wang; Michael S Lawrence; Youzhong Wan; Petar Stojanov; Carrie Sougnez; Kristen Stevenson; Lillian Werner; Andrey Sivachenko; David S DeLuca; Li Zhang; Wandi Zhang; Alexander R Vartanov; Stacey M Fernandes; Natalie R Goldstein; Eric G Folco; Kristian Cibulskis; Bethany Tesar; Quinlan L Sievers; Erica Shefler; Stacey Gabriel; Nir Hacohen; Robin Reed; Matthew Meyerson; Todd R Golub; Eric S Lander; Donna Neuberg; Jennifer R Brown; Gad Getz; Catherine J Wu
Journal: N Engl J Med Date: 2011-12-12 Impact factor: 91.245

8. Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia.

Authors: Rosa Lapalombella; Qingxiang Sun; Katie Williams; Larissa Tangeman; Shruti Jha; Yiming Zhong; Virginia Goettl; Emilia Mahoney; Caroline Berglund; Sneha Gupta; Alicia Farmer; Rajeswaran Mani; Amy J Johnson; David Lucas; Xiaokui Mo; Dirk Daelemans; Vincent Sandanayaka; Sharon Shechter; Dilara McCauley; Sharon Shacham; Michael Kauffman; Yuh Min Chook; John C Byrd
Journal: Blood Date: 2012-10-03 Impact factor: 22.113

9. High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations.

Authors: Jennifer Edelmann; Karlheinz Holzmann; Florian Miller; Dirk Winkler; Andreas Bühler; Thorsten Zenz; Lars Bullinger; Michael W M Kühn; Andreas Gerhardinger; Johannes Bloehdorn; Ina Radtke; Xiaoping Su; Jing Ma; Stanley Pounds; Michael Hallek; Peter Lichter; Jan Korbel; Raymonde Busch; Daniel Mertens; James R Downing; Stephan Stilgenbauer; Hartmut Döhner
Journal: Blood Date: 2012-10-09 Impact factor: 22.113

10. Mutations driving CLL and their evolution in progression and relapse.

Authors: Dan A Landau; Eugen Tausch; Amaro N Taylor-Weiner; Chip Stewart; Johannes G Reiter; Jasmin Bahlo; Sandra Kluth; Ivana Bozic; Mike Lawrence; Sebastian Böttcher; Scott L Carter; Kristian Cibulskis; Daniel Mertens; Carrie L Sougnez; Mara Rosenberg; Julian M Hess; Jennifer Edelmann; Sabrina Kless; Michael Kneba; Matthias Ritgen; Anna Fink; Kirsten Fischer; Stacey Gabriel; Eric S Lander; Martin A Nowak; Hartmut Döhner; Michael Hallek; Donna Neuberg; Gad Getz; Stephan Stilgenbauer; Catherine J Wu
Journal: Nature Date: 2015-10-14 Impact factor: 49.962

12 in total

1. Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1-derived peptides overcomes drug resistance.

Authors: Elodie Pramil; Linda Herbi Bastian; Thomas Denèfle; Fariba Nemati; Malina Xiao; Eva Lardé; Karim Maloum; Damien Roos-Weil; Elise Chapiro; Magali Le Garff-Tavernier; Frédéric Davi; Didier Decaudin; Marika Sarfati; Florence Nguyen-Khac; Hélène Merle-Béral; Philippe Karoyan; Santos A Susin
Journal: Blood Adv Date: 2019-10-22

Review 2. The resistance mechanisms and treatment strategies of BTK inhibitors in B-cell lymphoma.

Authors: Haoran Wang; Wentao Zhang; Jingyi Yang; Keshu Zhou
Journal: Hematol Oncol Date: 2021-10-15 Impact factor: 4.850

3. Gain of the short arm of chromosome 2 (2p gain) has a significant role in drug-resistant chronic lymphocytic leukemia.

Authors: Fotini Kostopoulou; Clementine Gabillaud; Elise Chapiro; Beatrice Grange; Julie Tran; Simon Bouzy; Michael Degaud; Hussein Ghamlouch; Magali Le Garff-Tavernier; Karim Maloum; Sylvain Choquet; Veronique Leblond; Jean Gabarre; Anne Lavaud; Veronique Morel; Damien Roos-Weil; Madalina Uzunov; Romain Guieze; Olivier A Bernard; Santos A Susin; Olivier Tournilhac; Florence Nguyen-Khac
Journal: Cancer Med Date: 2019-05-07 Impact factor: 4.452

Review 4. Overcoming Ibrutinib Resistance in Chronic Lymphocytic Leukemia.

Authors: Bartosz Puła; Aleksandra Gołos; Patryk Górniak; Krzysztof Jamroziak
Journal: Cancers (Basel) Date: 2019-11-21 Impact factor: 6.639

5. Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia.

Authors: Janek S Walker; Zachary A Hing; Bonnie Harrington; Jordan Baumhardt; Hatice Gulcin Ozer; Amy Lehman; Brian Giacopelli; Larry Beaver; Katie Williams; Jordan N Skinner; Casey B Cempre; Qingxiang Sun; Sharon Shacham; Benjamin R Stromberg; Matthew K Summers; Lynne V Abruzzo; Laura Rassenti; Thomas J Kipps; Sameer Parikh; Neil E Kay; Kerry A Rogers; Jennifer A Woyach; Vincenzo Coppola; Yuh Min Chook; Christopher Oakes; John C Byrd; Rosa Lapalombella
Journal: J Hematol Oncol Date: 2021-01-15 Impact factor: 23.168

Review 6. Selective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasms.

Authors: Suresh Kumar Balasubramanian; Asfar S Azmi; Jaroslaw Maciejewski
Journal: Leukemia Date: 2022-01-29 Impact factor: 12.883

Review 7. Keeping Cell Death Alive: An Introduction into the French Cell Death Research Network.

Authors: Gabriel Ichim; Benjamin Gibert; Sahil Adriouch; Catherine Brenner; Nathalie Davoust; Solange Desagher; David Devos; Svetlana Dokudovskaya; Laurence Dubrez; Jérôme Estaquier; Germain Gillet; Isabelle Guénal; Philippe P Juin; Guido Kroemer; Patrick Legembre; Romain Levayer; Stéphen Manon; Patrick Mehlen; Olivier Meurette; Olivier Micheau; Bernard Mignotte; Florence Nguyen-Khac; Nikolay Popgeorgiev; Jean-Luc Poyet; Muriel Priault; Jean-Ehrland Ricci; Franck B Riquet; Santos A Susin; Magali Suzanne; Pierre Vacher; Ludivine Walter; Bertrand Mollereau
Journal: Biomolecules Date: 2022-06-28